This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Pharmathen S.a.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Ioanna Georgopoulou: Innovator in Pharmaceutical Chemistry
Introduction
Ioanna Georgopoulou is a prominent inventor based in Salonika, Greece. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug preparation. Her work has led to advancements that benefit the pharmaceutical industry and improve patient care.
Latest Patents
Ioanna Georgopoulou holds a patent for a process titled "Process for the preparation of O-desmethyl-venlafaxine and salts thereof." This invention relates to a novel method for preparing O-desmethyl venlafaxine (ODV) and its pharmaceutically acceptable salts. The process includes the provision of a spiro-venlafaxine compound as an intermediate, the conversion of this intermediate into ODV free base in a one-pot process, and the optional conversion of ODV free base into pharmaceutically acceptable salts. Additionally, the invention encompasses novel processes for preparing crystalline salts of ODV-succinate and ODV-oxalate. She has 1 patent to her name.
Career Highlights
Ioanna Georgopoulou is associated with Pharmathen S.A., a company known for its innovative pharmaceutical solutions. Her role at Pharmathen has allowed her to focus on research and development, contributing to the advancement of pharmaceutical technologies.
Collaborations
Throughout her career, Ioanna has collaborated with notable colleagues, including Theoharis V Koftis and Alexandros Strongilos. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical sector.
Conclusion
Ioanna Georgopoulou is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation processes. Her contributions continue to impact the industry positively, showcasing her dedication to innovation and excellence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile